OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

← Alopecia UK

2025-03-31-accounts

Charity number: 1111304 (England and Wales) SCO44702 (Scotland)

ALOPECIA UK

UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

ALOPECIA UK

CONTENTS

Page
Reference and administrative details of the Charity, its Trustees and advisers 1
Trustees' report 2 - 16
Independent examiner's report 17
Statement of financial activities 18
Balance sheet 19
Notes to the financial statements 20 - 32

ALOPECIA UK

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 MARCH 2025

Trustees Henry Moore (appointed 15 December 2024)
Manisha Chana (appointed 24 May 2024)
Victoria Coombes
Catriona Kelly
Kimberly Brown
Steve Lindsey
Emma Hickinbotham
Lynn Wilks
Charity registered
number
1111304 (England and Wales) SCO44702 (Scotland)
Principal office
10-12 Commercial Street
Shipley
West Yorkshire
BD18 3SR
Chair
Ian Barney (appointed from April 2025)

Page 1

ALOPECIA UK

TRUSTEES' REPORT FOR THE YEAR ENDED 31 MARCH 2025

The Trustees of Alopecia UK present their report and the financial statements for the year ended 31 March 2025. The Trustees have adopted the provisions of the Statement of Recommended Practice (SORP) “Accounting and Reporting by Charities” issued in March 2005 in preparing the annual report and financial statements of the charity.

Reference and administrative information about Alopecia UK (Charity registration number, names of Trustees, etc.) is set out in the preface to this report.

The Trustees have complied with the duty in Section 7 of the Charities Act 2011, giving due regard to public benefit guidance published by the Commission.

1. About Us

Alopecia UK (AUK) was founded in 2004. Official charitable status was granted in September 2005.

The charity continues to develop, and we continue to progress our aims of Support, Awareness and Research with the overall mission statement of ‘working to improve the lives of those affected by alopecia’.

Our aims

• Support - We will provide impartial information, advice, and support to help people feel less isolated

• Awareness - We will raise awareness to the general public and healthcare professionals about alopecia and its psychological impact

• Research - We will provide hope and confidence to people with alopecia by funding research into its causes, with the aim of finding treatments, and ultimately, a cure.

Our values

• To be open, honest and act with integrity

• To appreciate the skills, expertise and commitment of our Staff, Trustees and Volunteers, many of whom have personal experience of alopecia.

2. Charity structure, governance and management

Governing Document

The Trust is an unincorporated trust, constituted under a Declaration of Trust dated 09 Apr 2005, as amended by Deed, dated 21 Aug 2005, and is registered Charity Number 1111304, and Scottish registered charity SC044702.

Trustees

C Philipsborn (Chair – stepped down April 2024), E Hickinbotham and K Brown Co-chairs May 2024 to March 2025), I. Barney (appointed Chair from April 2025)

L Wilks

E Hickinbotham S Lindsey K Brown C Kelly V Coombes M Chana (Treasurer – appointed 24th May 2024) H Moore (appointed – 15th December 2024).

L Rogers (Treasurer – stepped down 31st August 2024) S Vaghela (stepped down 31st August 2024).

Page 2

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Notable changes

C Philipsborn stepped down at the start of this reporting period in April 2024, and E Hickinbotham and K Brown stepped into interim Co-chair roles for this financial year. M. Chana appointed Treasurer during this reporting period on 24th May 2024. I. Barney appointed Chair just after the end of this reporting period in April 2025.

Trustees are appointed by the Trustees, following the consideration of applications received from individuals. The charity tries to ensure our Trustees have a varied background, each bringing a different skill to the board. All Trustees are DBS checked. Before appointing a new trustee, the board obtains a declaration that they are not disqualified, searches the register of removed trustees, and checks the insolvency register. Once appointed, Trustees receive a Code of Conduct document and are given information on their roles and responsibilities.

Oversight

The Trustee Board and CEO held Trustee Meetings in May 2024, August 2024, November 2024 and February 2025. The May meeting was held face-to-face, with the August and November and February meetings held digitally over Microsoft Teams. All Trustees could see and hear each other during all meetings. In between meetings, individuals communicated mainly via email and WhatsApp.

During the accounting period, all Trustees had input into the direction and decisions of the charity with some of them involved in the delivery. Charity activities were reviewed in quarterly Trustee meetings to ensure we continue to fulfil our mission, to improve the lives of those affected by alopecia.

Trustees have considered the major risks to which the charity may be exposed; have reviewed them and approved systems and procedures to manage appropriately. Meetings are minuted and include governance responsibilities, alongside operational content.

Staff

There were several staff changes during this period. One staff member left during the period, and one staff member was welcomed back from maternity leave at the end of this financial year. The core staff team was 8 people during this period. The team at the end of this financial year was the equivalent of 5.4 full time employees.

Volunteers

During the financial year we were supported by 129 active volunteers. 62 of these were new volunteers, recruited over the last 12 months, taking on roles such as Kids Activity Group Leaders, Support Group Leaders, Events Volunteers or Facebook Moderators. Volunteers were provided with induction training and a DBS check where appropriate.

There were 33 active Support Group Leaders over the last 12 months, volunteering a total of 755.5 hours to deliver and facilitate support group meetings across the UK. We also had 8 active Facebook Moderators, volunteering 2,444 hours over the last 12 months.

Support Group Leaders and Facebook Moderators are invited to take part in quarterly supervision sessions, where they can share any concerns and receive support from fellow volunteers. Other volunteers include the 19 members of our Lay Research Panel, 9 Trustees and professional supporters who give their time, skills and expertise pro-bono.

We're truly thankful for the time, energy, and dedication our volunteers give. Their passion, skills, and commitment play a big role in helping us achieve our goals with the moderate resources available. Importantly, our volunteers are also amazing advocates for our work and make a real difference in the lives of people affected by alopecia.ere...

Page 3

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

3. Charitable Activities

Support

Primary activities : Education and peer experiences via our website and newsletters, online peer support via our Facebook groups, face-to-face peer support group meetings (in person and online), national events, one-to-one support (calls and emails).

Supported by : Volunteer management, the impact of our Awareness and Research Aims work to those people who meet and treat people with alopecia with a more educated understanding.

Key achievements

Education and peer experiences via our website and newsletter s

We work to make our website helpful and informative for people at all stages of their alopecia journey. It's a constant work in progress, with new pages, blog posts, and news updates added throughout the year.

During this period, new resources were added to our website as we continued to expand the ‘Advocate for yourself’ section. ‘How to get the most out of a dermatology appointment’ and ‘How to advocate for yourself within the NHS’ were designed to help our community get the most out of medical appointments and navigate some of the challenges currently being faced in the NHS.

We have plans to continue to develop new content for the ‘Advocate for yourself’ and ‘Living well with alopecia’ sections of the website in the months ahead.

The South Asian Health Foundation published its ‘Health Equalities: Full Stop’ report. Alopecia UK was proud to support the report with an article titled ‘Is alopecia treatment becoming a story of the haves and the have-nots?’, continuing our work in the advocacy space.

We were delighted to support Saha, an alopecia awareness and fundraising event with some incredible musicians. We’d like to thank Alopecia UK supporter Hetal Peshvaria who organised the event which was designed to raise awareness in the South Asian community.

Our newsletter mailing list has increased by 8% from 3,936 recipients to 4,251 at the end of the financial period. During this period 57 businesses paid to be listed on our Service Directory. As well as providing information about products and services helpful to those with alopecia, the Service Directory contributes to our charitable income. Thank you to all the companies who pay to be listed on our Service Directory.

Online peer support via our Facebook groups

We facilitate 4 private Facebook groups, each moderated by our amazing volunteers, to help create spaces for peer support and shared learning. These include our main Alopecia UK group, the Products and Services Chat, Men’s Chat, and Parents Chat. Our private Facebook Groups remain our primary online peer support platform and a popular way for people to connect with others affected by alopecia.

This year, membership across all groups increased by 2,050 members — a 10% rise compared to the previous year — bringing total membership across the four groups to 23,585 by the end of March 2025. Our staff and volunteer moderators continue to work hard to maintain safe, welcoming communities.

In 2024/25, we added 298 staff-written support comments across Facebook and Instagram, a significant increase from just 17 in 2023/24. The time spent providing social media support rose from 3 hours to 59 hours, reflecting the increased demand for timely, empathetic responses.

Our Facebook groups continue to play an invaluable role in helping people affected by alopecia feel connected, informed, and less alone.

Page 4

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Our 8 Facebook Volunteer Moderators approved over 2,000 posts and over 1,100 membership requests across our two largest Facebook groups (Peer Support and Products & Services Chat) in 2024/25.

Without their ongoing contribution, our online peer support spaces would not be as safe, welcoming, and vibrant as they are. Their dedication has been instrumental to the charity’s ability to offer peer support consistently across the year, ensuring high standards and safety within our community spaces.

Face-to-face peer support group meetings (in person and online)

Over the last 12 months, our volunteer support group leaders held 144 group meetings, across the UK, (an increase of 56.52%), welcoming 1,040 attendees (an increase of 46.07%).

Alongside these face-to-face meetings we ran 11 online support group meetings for adults affected by alopecia, which provided a space for 100 attendees to connect with others affected by hair loss.

Our Support Groups continue to help those who attend, as demonstrated in some of the feedback received in the past 12 months:

“The opportunity to listen to and share experiences with other alopecia patients was tremendous, I hadn’t realised how much I needed this support group”

“My Support Group Lead makes me feel 100% confident to be at the group and be able to share and speaking in the group meetings with others as that is definitely something I do not do with family or friends to talk about my hair loss.”

“My support group leader is extremely empathetic, offering wonderful support. I was very nervous about joining the group but have been made very welcome.”

During this accounting period, following the Access Foundation grant funding we gratefully received this year, we held 7 Kids Activity Groups across the UK, which welcomed 151 attendees, including 45 children with alopecia. Our volunteer led, Kids Activity Groups continue to be a success. Our plan is to continue to use the remaining grant to offer more of these opportunities to children and their families who have been affected by alopecia.

Youth Voice Board

Our Youth Voice Board (YVB) is made up of 11 active members. We held 4 meetings during this period, with 23 attendees overall. This group of young people, all aged 15+ help to guide the charity to help create new resources for teens, with many balancing college, university, and other priorities.

Our Alton Towers, in April 2024, remained a key highlight, with YVB members showing real leadership and enthusiasm. They set up and ran a "Journalism Booth," interviewing community members, managing recording and editing themselves, and creating a welcoming environment for new attendees.

The YVB’s Instagram account reached 10,500 accounts this year, reflecting strong peer-led engagement. While attendance slightly declined as members’ lives became busier, their commitment and contribution remained strong. We have opportunities for YVB members to transition into adult volunteering roles with the charity.

Youth Network

Following the cancelation of some summer sessions this year, Youth Network engagement levels were noticeably lower compared to previous years. We see that teenagers have many competing demands (education and holidays) in the summer months. Moving forward, we plan to deliver a term-time programme of Youth Network sessions, delivered either monthly or every two months, with the aim of providing more consistent continuity and maintain engagement. Youth Voice Board members will continue to contribute to the wider Youth Network, and specialist external facilitators we be invited to deliver occasional themed workshops or events.

Page 5

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

National events

In April 2024, we were thrilled to host our 9th trip to Alton Towers. It was a fantastic day filled with awareness, support, and plenty of fun. We welcomed 272 attendees, including 17 amazing volunteers and 6 staff members. Among our group were 105 wonderful people with alopecia, joined by their supportive families and friends.

This event continues to help those who join, as demonstrated in some feedback from the 2024 event: “It was incredible to see the resilience of all the children there. My daughter usually wears a wig, but happily goes without at these events. They make her feel strong, and able to chat to others about their experience managing alopecia. Its also really great for the volunteers to be there and offer the 'adult' perspective for some of the older children, again to look up to.”

“I think the event is well organised and well run. I like the groups going round together and the volunteers are great. The event helps to normalise Alopecia in so many ways, and you can see the confidence the children get from the event.”

We were delighted to host our Kingswood residential weekend event for children aged 7-17 for the third time in August 2024. We welcomed 92 attendees from 23 families. All those who provided feedback said that they’d recommend this event to others, with feedback including:

“It's a fantastic opportunity for children to see that they're not alone, and that alopecia doesn't define you. They also get to see that children and adults can lead very happy, fulfilling lives.”

One-to-one support (calls and emails)

In 2024/25, there was a significant increase, 148%, in support enquiries, particularly across Email and Social Media. Overall, 167 hours and 34 minutes of additional time, an increase of 257%, was recorded compared to the previous year ending March 2024.

Over the last 12 months, 77% of support enquiries came from first-time contacts, demonstrating strong new reach and engagement. The majority of enquiries, 68%, came from adults living with alopecia, with a smaller but important proportion from parents or carers supporting children, and a small number from medical professionals and schools. 83% of enquiries were from females.

While emotional support remains a key theme, there has been a noticeable increase in practical enquiries, with people seeking help accessing dermatology services, understanding treatment options such as JAK inhibitors (like ritlecitinib), and finding peer support groups.

We also continued to build our Facebook community groups, with more individuals reaching out for peersupport, advice and reassurance through posts and comments, helping us to increase both accessibility and visibility. Through support calls, emails and social media, we continue to operate a signposting service to other charities that offer professional one-to-one support as a core part of their provision. Overall, feedback from our community continues to be positive, with individuals highlighting the reassurance, kindness, and practical help they received.

“Thank you so much for your response. I appreciate the effort in providing the links. I also want to take a moment to thank you for your empathetic and kind response, something that has been incredibly lacking elsewhere. I appreciate it more than I can express.”

“Thank you for this information, it is reassuring to have this. I think that I will speak to my GP because it is really affecting my wellbeing. I will also look at the other resources you have sent me and look at some local support groups too.”

Page 6

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

4. Awareness

Primary activities with the general public : Website content, social media presence, media, newsletter, ambassador partnerships, September alopecia awareness month, merchandise sales.

Primary activities as experts : Networking and attendance at conferences, patient advocacy with healthcare bodies and related organisations, provision of resources and expertise (externally and on our website).

Key achievements

Website and social media presence

Our reach is important for raising awareness and normalising alopecia with the public. For many, our website is the first source of education. During this period 212,888 website users viewed 489,160 webpages in 272,521 sessions, representing a slight increase on website usage from the previous period.

We continue to facilitate active and engaging social media platforms, with regular content providing support and awareness to over 40,000 followers across all platforms (Facebook, Instagram, X and LinkedIn).

Media

We have continued to support coverage of alopecia in the press and for TV pieces by finding case studies for journalists and provided charity quotes when requested. We are proud of the part played in supporting the producers in finding contributors and fact-checking information for a BBC documentary 'My Alopecia and Me', played in full on BBC Breakfast om 31st August 2024. This 26 min long documentary featured interviews and soundbites from a variety of people in the alopecia community, with different experiences with alopecia. We are thrilled that it was played to such a large audience and expect millions of people will have received some alopecia awareness as a result.

Ambassadors

Thank you to Joanna Rowsell MBE, Joelle, John Altman, Fateh Singh, Will Smallbone and Zoe Lyons for their ongoing support of Alopecia UK. Special thanks to Joanna for attending our Alton Towers event. Supporting others as they raise awareness

We are grateful to have awarded a fourth Hannah Dennis Alopecia Awareness Award to Tommy, who raised awareness in his school, organising a wear something blue fundraising day, Tommy also completed 101 star jumps every day in September Awareness month 2023, raising funds and awareness via social media and local media coverage. Congratulations to Tommy.

Also in this period, we advertised media opportunities to our community and continued to provide individuals with resources to do their own awareness activities in school, colleges and workplaces. We responded to 143 enquiries for teachers, parents and education professional to receive our schools pack.

September - Alopecia Awareness Month – Charity Champions

For our fifth year, we recruited ‘Charity Champions’ to raise awareness during Alopecia Awareness Month (September) and raise funds for Alopecia UK. We had more than 50 Charity Champions take up our call to ‘Go The Distance’ and saw lots of creativity with how they interpreted that challenge. Charity Champions raised over £32,000 for Alopecia UK through a mixture of challenges including running, walking, swimming, dancing, coffee mornings and many more.

Networking, conferences and speaking

Alongside the research memberships outlined later in this report, we maintain positive relationships and, where available, have memberships with NCVO (The National Council for Voluntary Organisations), The VTCT Foundation, British Association of Dermatologists (BAD), The Dermatology Council for England (DCE), British Dermatological Nursing Group (BDNG), British Hair and Nail Society (BHNS), Centre for Appearance Research (CAR), Primary Care Dermatology Society (PCDS), College of Trichological Science and Practice (CTSP), Psychodermatology UK and The National Institute for Health and Care Excellence (NICE).

Page 7

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

The team continues to respond to opportunities to speak and run workshops. During this period, our CEO, Sue Schilling, attended Appearance Matters 10, an international biennial conference hosted by the Centre for Appearance Research at the University of West of England. The event focused on the psychological and social aspects of appearance differences, including dermatology conditions like alopecia.

Sue, and Trustee Lynn Wilks, attended the 104th meeting of the British Association of Dermatologists. Sue and Lynn hosted a charity stand at the event and engaged with many clinicians, discussing alopecia treatments, support, and wig provision concerns. This helped raise awareness of the charity amongst doctors but also provided an opportunity to connect with many people who add incredible value to Alopecia UK. Special thanks to Dr Marianne de Brito who spoke at this year’s conference, on behalf of Alopecia UK, about the challenges within NHS wig provision.

We attended the British Dermatological Nursing Group’s conference in Harrogate, speaking to many nursing staff about how we can support their patients. Sue also spoke at the British Hair and Nail Society’s training event for new registrars.

Our Communications Manager, Amy Johnson, spoke at a meeting attended by over 40 hairdressing and barbering college teachers, raising awareness of alopecia and encouraging teachers to train new hairdressers and barbers about alopecia. After all, they are often the first people to spot it.

Sue and Amy attended the ‘All About Alopecia’ event organised by Vocal, on behalf of NIHR Manchester Biomedical Research Centre. Dr Matthew Harries and his team presented on the latest research and treatments. Alopecia UK supported with a session about living with alopecia, and Sue gave a talk about what the charity can offer people with alopecia.

Patient advocacy with healthcare bodies and related organisations

We continue to develop the ‘Advocate for yourself’ section on our website. Over the last 12 months we have added information about ‘How to get the most out of a dermatology appointment’ and ‘How to advocate for yourself within the NHS’. Going forward we plan to keep developing and expanding the content for the ‘Advocate for yourself’ and ‘Living well with alopecia’ sections of the website.

During the financial year, as well as representing the patient voice at several forums with the above groups, we have also launched our Community Survey. The survey formed part of our advocacy work with Principle Consulting to campaign for fairer treatment pathways. In 2025, we will publish our report, Health Inequalities in Plain Sight, which highlights the challenges that people with alopecia face within the NHS and identifies areas for improvement. Financial support for the report was provided to Alopecia UK, as a grant, from Pfizer Ltd.

We also joined forces with other leading health charities as the Partnership for Change to call for urgent improvements in how the NHS coordinates care for patients. The group, which includes Blood Cancer UK, Fight Bladder Cancer, Genetic Alliance UK, Kidney Care UK, Meningitis Now, Sickle Cell Society, The Migraine Trust, and the Patients Association, has recently submitted its recommendations to the government as part of the consultation on the NHS’s new 10-year plan. Supported by funding from Pfizer, these charities aim to ensure patients’ voices are heard and care coordination becomes a central focus of future NHS reforms. The full report, "Better Care: Transforming Care Coordination in the UK," will be published in Spring 2025.

Merchandise

Our charity merchandise continues to be a fun and effective way to spread the word about our cause. It helps in three important ways:

Page 8

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

5. Research

Primary activities: Research Pots Grant Scheme, PhD Bursaries Grant Scheme, run an advisory expert Research Committee and Lay Research Panel, Patient and Public Involvement (PPI), network and build relationships to stimulate and support alopecia research, share research updates with our community, communicate our impact, and attend research relevant forums to stay informed on developments.

Secondary activity: Collaborate or lead on commissioned research

Alopecia UK became involved in research via the Hair Loss Priority Setting Partnership (PSP) in 2013. We have funded research projects with a range of aims including understanding causes, finding new paths to treatments, and helping people manage the psychological burden of hair loss. Every project is approved by our scientific advisory Research Committee and our lived experience Lay Research Panel, to make sure we are supporting research of the highest scientific quality and relevance to patients.

Since 2018 we have held an annual research grant round for small projects. Up to March 2025, we have awarded a total of 17 research grants in this way. In addition, we took over one project (the Glasgow Alopecia Areata Biobank) funded by AAR-UK. This grant is now completed but the Biobank continues to operate with funding from other sources. From the projects directly funded by AUK, 10 are now completed, with final reports received. In addition, the PhD bursary we awarded in 2022 to the ‘Alopecia Areata Rapid Access Clinic (AA-RAC)’ project entered its second year in October. Including the PhD, 8 projects were ongoing at the end of this financial year.

Research funding

Following our 2024 Research Pots Awards, two projects were awarded funds in April 2024. These awards were made from the legacy fund for alopecia areata research, and the projects started in June: - Platelet hyperactivity in alopecia areata. Dr Matt Hindle, Leeds Beckett University. £14,387.00 - Systematic development of a complex psychosocial intervention to improve wellbeing and quality of life in alopecia areata. Dr Miglena Campbell, Teesside University. £59,910.00

Up to this year, we had been holding our Research Pots Grants round annually. However, with a view to increasing capacity in alopecia research, we instead held a PhD Bursary round with the aim of awarding funds to two 3-year projects. These are set to train new investigators in alopecia research and address key priorities from the Priority Setting Partnership for alopecia areata, with funds coming from the legacy for alopecia areata research. Following a review process, a decision on funding awards will be made in Q1 of the next financial year. This is set to take the amount of PhD bursaries awarded up to 3, including the ongoing project at the University of Manchester.

Research Committee

As members of the Association of Medical Research Charities, we continue to follow their guidance on rotation of the Research Committee. As a result, this year three members stepped down and were succeeded by three new members. The new members had the same professional backgrounds as those stepping down, with two basic scientists and one consultant dermatologist. In addition, the chair Professor Simon Milling was one of those stepping down. He was succeeded in his role by existing committee member Professor Desmond Tobin, who said this about his reasons for continuing to support our charity:

“Disorders affecting the hair are sadly often seen as the Cinderella of Dermatology (with Dermatology the Cinderella of Medicine). Thus, alopecia researchers and patients often find themselves at the back of the queue, when it comes to attracting the attention of funding agencies and medical providers. Organisations like Alopecia UK are therefore enormously important, both as a beacon of support for both patients and researchers of hair disorders as well as a coordinator of efforts to drive progress in this area of medicine with still so many unmet clinical needs.”

Page 9

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

Supporting Researchers

We have also continued to support researchers who get in touch looking for help with their research and supported 20 projects across the year. This included promotion of 11 studies to aid recruitment, of which two were AUK-funded projects. In addition, we supported 9 projects with Patient and Public Involvement (PPI) throughout the year.

With funders and regulators across the research landscape placing increased importance on involvement of patients and the public in research, we have seen an increase in the number of requests for this type of support. Our Lay Research Panel (LRP), made up of people with lived experience of alopecia, continues to be engaged in supporting research, and membership grew to 18 this year. PPI activities included reviewing of documentation for projects, joining advisory groups, supporting clinical guideline development, meetings to discuss funding proposals, and a Delphi consensus study. Examples of projects supported include the Global Registry of Alopecia Areata disease Severity and treatment Safety (GRASS) UK project, for which 8 parents and their children reviewed patient-facing documents. In addition, the AUK-funded project which aims to develop a psychosocial intervention for alopecia areata saw 4 LRP members join their advisory group. Further, one LRP member joined the British Association of Dermatologists’ (BAD) alopecia areata guideline development group, alongside AUK staff member Amy.

We encourage researchers to involve patients in all aspects of research, including helping design and shape projects. For the 2025 PhD bursary round, LRP members supported three teams of researchers with the development of their application. LRP members reviewed the lay summary of one application and held virtual meetings with two more research teams to discuss their proposal and plans for involvement.

Feedback received from panel members has been positive, saying they have enjoyed supporting researchers and the charity by getting involved in research and helping review funding applications. For example, one panel member said:

“I appreciate the opportunity to provide feedback on research, particularly from a perspective of lived experience. It's crucial that studies actively seek and incorporate diverse cultural backgrounds and perspectives to ensure inclusivity and relevance. Additionally, the consistent updates regarding alopecia research have been genuinely appreciated; it's reassuring to see such sustained progress in this area.”

Another panel member said:

“I like to get involved as I’m very interested and passionate about finding new developments and treatments for alopecia, and to help the generations to come have better support than I have had since I was diagnosed back in the 1980s.”

Network and build relationships to drive researchers towards alopecia

We continue to link in with any research networks and opportunities where possible. This involves membership of the Association of Medical Research Charities (AMRC), AMRC Research Management Working Group, Charities Research Involvement Group (CRIG), European Hair Research Society (EHRS), International Alliance of Dermatology Patient Organisations (IADPO), and associate membership of the Connect Immune Research (CIR) partnership. We are also a National Institute for Health Research (NIHR) Research Delivery Network (RDN) non-commercial partner.

In April 2024, our Research Manager attended the World Congress for Hair Research, in Dallas, USA, connecting with many global leaders in hair research, including leading clinicians. An update with learnings from this event was shared on the Alopecia UK website.

Page 10

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

6. Equality, diversity and inclusion

Going forward, we have identified one of our three key strategic goals is to increase our reach to help more people affected by alopecia who want support but aren’t currently accessing Alopecia UK, particularly in communities where we are not yet visible. This highlights our commitment to promoting diversity, inclusion, and fairness across everything we do. Our aim is to better support everyone affected by alopecia—including individuals and families from underrepresented or diverse backgrounds. While creating equal access to services and research isn’t always easy, we believe it’s essential. Alopecia can affect anyone, with studies showing alopecia has a higher prevalence among people from non-white ethnicities, and those in urban or disadvantaged areas. Currently, our community doesn’t fully reflect that diversity, and we want to change that by building a more inclusive charity for all.

This year, the South Asian Health Foundation published its ‘Health Equalities: Full Stop’ report. Alopecia UK was proud to support the report with an article titled ‘Is alopecia treatment becoming a story of the haves and the have-nots?’, continuing our important work in the advocacy space.

We know that this will take time, expertise and financial investment, it will be an important factor of our future strategy. We are committed to take the necessary steps to ensure our support, information and resources are accessible, relevant and meet the needs of people living with alopecia particularly amongst underserved communities.

7. Plans and priorities

Continuation of Support Amid Changing Healthcare Access

In the past year, Alopecia UK has heard about notable decline in access to dermatology services and wig provision from our community. This is reflected in our support calls and emails where we are hearing from increasingly distressed people and frustration in our community. Once again, we are highlighting the importance of our support model, building connections among individuals with alopecia remains at the heart of our mission. So, during the next period our regional kids' activity groups and the youth network which were piloted this year will continue, alongside our adult face to face support groups and restarting our online adults’ meetings.

We will also run the Alton Towers and family residential event again and are in early stages of planning our Big Weekend event for 2025. This event aims to bring together researchers, healthcare professionals, and individuals with alopecia to discuss the latest advancements and share knowledge, further strengthening the connection between the community and ongoing research.

We’d like to thank our dedicated volunteers without whom our support events would not be possible. The recent approval of the first treatment for alopecia, Ritlecitinib, by the NHS, while a milestone, will introduce more variability in patient access based on geographic location. This "postcode lottery" in treatment availability underscores the importance of our advocacy efforts and we remain committed to advocating for equitable access to treatments and services. We strive to make an impact for the broader community, so in 2024/25 our advocacy work with health care bodies and industry partners remains a priority, albeit it often in the background and invisible to our community at large.

In parallel, we strongly believe that people with alopecia should be able to live well and with confidence. We know this is as legitimate a life choice as access to a medicalised treatment. In 2024/25 Alopecia UK will continue to celebrate those who are living well with their alopecia by way of blogs, social media and commercial media. We are committed to championing patient choice.

Strategic Review and Future Goals

Alopecia UK is in a relatively strong position with its reserves, but we face ongoing challenges related to fundraising income, rising costs, and increasing demand for our services. As a small charity with limited financial, human and material resources we need to prioritise initiatives that align with the charity’s mission and goals.

Looking forward, we are undertaking a review and update of our charity-wide strategy. All elements of our work are included in the review including where we focus of our day-to-day work, and refreshed strategies

Page 11

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

related to our aims and how we will fundraise for them. Our review will also look at our legal structure and technological infrastructure, it is crucial that we have the foundations right for long term sustainability. We aim to enhance our effectiveness and ensure that our efforts are aligned with the evolving needs of the alopecia community, whilst not spreading ourselves too thinly.

We are determined to help people with alopecia navigate the challenges posed by changing and inconsistent healthcare access and to continue making a meaningful impact in the lives of those we serve.

Page 12

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

8. Financial Review

The annual income generated by the Charity is to be applied for charitable purposes in accordance with the Trust’s objective. Year on year the trustees intend to make a significant distribution of available income, subject to making adequate reserves for known and potential liabilities and commitments, where applicable. Any amounts not so distributed are accumulated in the unrestricted fund.

Income highlights

Total income: £282,272 which is comparable to the previous period (£283,803). 10% (£29,506) of our income this was assigned as restricted and was largely made up of an £20,500 grant from Pfizer for our advocacy project, a £1,000 from the Fort Foundation for Kingswood 2024 and £5,000 grant from the Access Foundation for our Kids Activity Groups.

Our unrestricted income was £252,766, a 4% increase from £243,541, compared to the previous year that ended March 2024. This income is a result of an increase in our fundraising income.

Donations

Our unrestricted donations increased by 5% to £51,878. Thanks also to Enterprise Mobility for their donation of £2,500, Cheltenham Bowling Club for their donation of £2,000, Spirax Sarco for their donations totalling £1,300, and Pipeline Technology Centre Ltd for their donation of £1,000.

Thanks to the continued support of Lyndsey Brack of Diamond North East Wig Bank. We received donations totalling £2,152 from Lyndsey’s wig bank during this period.

Charitable activities

Our fundraising increased by 11% to £129,171. We believe the increase is partly due to continued growth in the popularity of challenge events, an increase in the range of events our fundraisers can access, via Run for Charity, as well as 5 fundraisers who used their public ballot places for the 2025 London Marathon. 198 individuals took part in fundraising events and challenges this year. Thanks to everyone who sponsored a friend or family member and to everyone who took part in a fundraising event this year. They include 12 runners at the 2025 Great North Run raising a combined total of over £7,840, Neil Henderson and his team who took on various running and cycling challenges raising £6,152, Quinton Newcombe and Team Fieldfisher who ran the Vienna Marathon and raised £5,457, Sarah Parker and her team who completed the Glasgow Kiltwalk raising £3,105, Miranda Mackaness who raised £3,017 and Ali Morrison who raised £2,638 both during September Awareness month.

Our events income decreased due to there not being a Big Weekend event this year. We did however see the return of our popular Alton Towers event in April 2024 and Kingswood Residential in August 2024.

Our income is largely driven by individual givers and our Alopecia Awareness Month appeal in September is an important contributor, this year we attribute over £32,000 to that campaign.

We are grateful to those people who support us with regular giving. By the end of March 2025, our regular donors donated a total of £1,452 a month to Alopecia UK. Regular donations are an important income

Page 13

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

source for the charity, and we will look to ways to continue to grow the number of regular donors in the future.

We have reported a 4% increase in our unrestricted income for the year, however, with inflation, and increasing overhead costs for charities across the UK, we know we will need to continue to look at strategies to increase income in the future. Our reserve policy provides some comfort in respect of meeting our ongoing obligations however we hope that our loyal supporters continue to support us. We also hope that our impact will attract new advocates for the charity.

Technology, office costs and insurances were as expected year-on-year, except for a small amount of expenditure on replacing aged equipment and on providing equipment for new members of staff. We spent more on governance than previous year; in providing training opportunities for our trustees and on consultancy fees linked to developing the next 3-year strategy, we always aim to keep governance costs as low as possible whilst ensuring the charity remains safe through correct training and oversight.

As well as using our charitable funds to deliver the activities described within these accounts, we have also used funds for generating voluntary income by pre-purchasing places for the 2024 Great North Run, London Marathon Gold Bond and annual subscription and access to events via Run for Charity. Combined this cost £4,507.

Page 14

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

9. Future plans

Looking forward to 2025/26

During 2024/25 Alopecia UK developed and a new three-year strategy which is being presented for sign off to our Board in May 2025, just after this financial year. The key strategic goals are, to improve our support model, to increase our reach and to strengthen our organisational structure and resourcing. Delivering these three goals will ensure we are working towards our vision with clear strategic direction and intentionality. As we look to the next financial year, and our 20th anniversary as a registered charity, there are several key areas we will be focussing on to ensure the correct foundations are in place to deliver this new strategy. In the next year, we will be prioritising a project to develop a new fundraising strategy to ensure the financial sustainability and health is in place for the years to come. We are aware any new fundraising strategy will take time before we see an increase to our income. Considering this, we have budgeted for staff costs of £250,720 for the next financial year, some of which will be used to engage consultants with programme specific skills. Therefore, in the meantime, we will continue to draw upon reserves during the next 12-18 months this may also bring our reserves to below 12 months of running costs, as per our policy.

We will focus on ensuring we have the necessary and appropriate charity structure, governance and processes in place to ensure long-term sustainability and make Alopecia UK fit for the future.

A key focus for this financial year will be to initiate a review of our support model with a view to better understand the needs of our community, how these can be best met with the aim to improve the support we provide. To do this we expect to invest a small amount of funds to complete this project however we will seek to leverage funding opportunities wherever possible.

We are encouraged by last year’s increase in fundraising income. We expect that this will continue to grow steadily over the next 12 months, we have secured a Gold Bond with the London Marathon which will result in 4 places each year for the next four years. We will continue to purchase places for the Great North Run again and ask our community to fundraise for us via these. Last year we expanded the range of challenge events available to our fundraising community, via Run for Chairty, this is something we will continue to promote and utilise with our fundraisers.

We will continue the spend the remaining National Lottery Funded Awards for All programme, and Access Foundation grants to provide region activities for children and young people with alopecia and their families. The feedback we have received from previous attendees has confirmed the value and positive impact that these activities have on the lives of young people living with alopecia. We plan to continue to deliver more of these events going forward. We will also deliver our Big Weekend Adult support conference, which means our events income and expenditure will be higher than this year.

Volunteers continue to be vital to our charity’s achievements. Our team of dedicated and committed volunteers is crucial to the success of the charity. Our volunteers help to run adult support groups, facilitate kids activity sessions, help delivery events and are valuable members of our Lay Research Panel. We will continue to invest in supporting and training our current volunteers as well as recruiting and onboarding new volunteers. We will continue to deliver our regional support groups and look to targeting strategic regions where the population is largest and culturally diverse. This will run alongside our strategic goal to increase our reach to help more people affected by alopecia who want support but aren’t currently accessing Alopecia UK, particularly in communities where we are not yet visible. We also plan to deliver our popular Alton Towers event again this year as well as our next Big Weekend which is scheduled for September 2025.

Following the process of refreshing our research strategy this year, we held a PhD Bursary grant round with the aim of awarding funds to two 3-year projects, previously this was done annually. We hope this will result in increased capacity in alopecia research. A decision on funding awards will be made in Q1 of the next financial year. We expect that this will increase the amount of PhD bursaries awarded up to 3.

Page 15

ALOPECIA UK

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025

As we look ahead to the next three years, we're confident that the work we've done to shape our new strategy will help guide our financial decisions during this time.

When we compare Alopecia UK to other national charities of a similar size, we're pleased to see that we're in a relatively strong financial position—especially thanks to our healthy reserves. That said, we do face some of the same challenges as others in the sector, such as slow growth in our income alongside rising costs, and a continued reliance on fundraising and donations. While this year’s deficit in our accounts isn’t unusual, we will continue to monitor things closely as well as diversifying and exploring new income streams as we move forward.

10. Reserves Policy

As a charity, Alopecia UK, relies almost entirely on the generosity of our supporters through voluntary donations, grants and fundraising activities. As a result, the trustees believe that it is essential to have significant funds to ensure the charity can continue to operate in the event of a temporary reduction in income. Our policy is that unrestricted funds should be maintained at a level equivalent to 12 months running costs. The Trustees consider that this level will ensure that in the event of a material drop in funding they will be able to continue the charity’s activities while looking at other ways to raise funds.

As a result, the Trustees have implemented a prudent accounting method to establish an annualised budget, on a rolling basis, to quantify the costs of meeting the charity’s needs for the forthcoming 12 months.

Many charities of similar size to Alopecia UK struggle to maintain 6-12 months of reserves, with the NCVO's Charity Almanac reporting that over 50% of small and medium charities have less than 6 months of reserves. In this respect, Alopecia UK is in a stronger-than-average financial position, which gives it some flexibility in managing potential shortfalls in the short to medium term, at least.

Additionally, the budget we have set will see these reduce to below 12 months of running costs over the next 18 months, or so. As a Charitable Trust, we feel that 12 months of running costs is an appropriate level of risk for our Trustees who have personal liability. Given our reliance on individual giving the charity will continue to work on a strategy for more diverse and long-term income streams. This will improve our ability to forecast spending.

Approved by order of the members of the board of Trustees and signed on their behalf by:

IR Barney IR Barney (Dec 13, 2025 14:50:21 GMT)

Ian Barney Chair of Trustees Date: 12 December 2025

Page 16

ALOPECIA UK

INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 MARCH 2025

Independent Examiner's Report to the Trustees of Alopecia UK ('the Charity')

I report to the charity Trustees on my examination of the accounts of the Charity for the year ended 31 March 2025.

Responsibilities and Basis of Report

As the Trustees of the Charity you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the 2011 Act').

I report in respect of my examination of the Charity's accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent Examiner's Statement

Your attention is drawn to the fact that the Charity has prepared the accounts in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has been withdrawn.

I understand that this has been done in order for the accounts to provide a true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the Charity as required by section 130 of the 2011 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Steven Kirkbride Signed: Steven Kirkbride (Dec 14, 2025 20:00:59 GMT)

Dated:

Steven Kirkbride ACA BFP

Armstrong Watson LLP

Chartered Accountants Carleton House 136 Gray Street Workington Cumbria CA14 2LU

Page 17

ALOPECIA UK

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2025

Note
Income from:
Donations and legacies
13
Charitable activities
14
Other trading activities
15
Investments
16
Total income
Expenditure on:
Raising funds
17
Charitable activities
Total expenditure
Net expenditure
Transfers between funds
25
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward		 Unrestricted
funds
2025
£
78,672
144,955
27,563
1,576
252,766
6,998
313,313
320,311
(67,545)
4,603
(62,942)
297,574
(62,942)
234,632		 Restricted
funds
2025
£
120
28,642
-
744
29,506
-
93,128
93,128
(63,622)
(4,603)
(68,225)
393,523
(68,225)
325,298		 Total
funds
2025
£
78,792
173,597
27,563
2,320
282,272
6,998
406,441
413,439
(131,167)
-
(131,167)
691,097
(131,167)
559,930		 Total
funds
2024
£
79,721
170,815
30,954
2,313
283,803
6,725
332,384
339,109
(55,306)
-
(55,306)
746,403
(55,306)
691,097

The Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 20 to 32 form part of these financial statements.

Page 18

ALOPECIA UK

BALANCE SHEET AS AT 31 MARCH 2025

Note
Fixed assets
Current assets
Stocks
22
Debtors
23
Cash at bank and in hand
Current liabilities
Creditors: amounts falling due within one
year
24
Net current assets
Total assets less current liabilities
Net assets excluding pension asset
Total net assets
Charity funds
Restricted funds
25
Unrestricted funds
25
Total funds		 2,500
29,181
565,794
597,475
(37,545)		 2025
£
-
559,930
559,930
559,930
559,930
325,298
234,632
559,930		 2,500
37,044
683,396
722,940
(31,843)		 2024
£
-
691,097
691,097
691,097
691,097
393,523
297,574
691,097

The financial statements were approved and authorised for issue by the Trustees on 12 December 2025 and signed on their behalf by:

IR Barney

IR Barney (Dec 13, 2025 14:50:21 GMT)

Ian Barney

Chair of Trustees

The notes on pages 20 to 32 form part of these financial statements.

Page 19

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

11. General information

Alopecia UK is a an unincorporated charity registered in England, Wales and Scotland. The principal address is 10-12 Commercial Street, Shipley, West Yorkshire, BD18 3SR.

12. Accounting policies

12.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.

The financial statements have been prepared to give a 'true and fair' view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair' view. This departure has involved following the Charities SORP (FRS 102) published in October 2019 rather than the Accounting and Reporting by Charities: Statement of Recommended Practice effective from 1 April 2005 which has since been withdrawn.

Alopecia UK meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

12.2 Income

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.

12.3 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on raising funds includes all expenditure incurred by the Charity to raise funds for its charitable purposes and includes costs of all fundraising activities events and non-charitable trading.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

All expenditure is inclusive of irrecoverable VAT.

Page 20

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

12. Accounting policies (continued)

12.4 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

12.5 Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.

12.6 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

12.7 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

12.8 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost.

12.9 Financial instruments

The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

12.10Pensions

The Charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charity to the fund in respect of the year.

Page 21

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

12. Accounting policies (continued)

12.11Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

12.12Taxation

The charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

13. Income from donations and legacies

Unrestricted
funds
2025
£
Appeals and Donations
51,878
Gift Aid reclaimed
26,794
78,672
Unrestricted
funds
2024
£
Appeals and Donations
49,210
Gift Aid reclaimed
22,391
71,601		 Restricted
funds
2025
£
120
-
120
Restricted
funds
2024
£
8,120
-
8,120		 Total
funds
2025
£
51,998
26,794
78,792
Total
funds
2024
£
57,330
22,391
79,721

Page 22

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

14. Income from charitable activities

Unrestricted
funds
2025
Restricted
funds
2025
£
£
Events and Fundraising
144,955
-
Trusts and grants
-
28,642
144,955
28,642
Unrestricted
funds
2024
Restricted
funds
2024
£
£
Events and Fundraising
139,505
-
Trusts and grants
-
31,310
139,505
31,310
15.
Income from other trading activities
Income from non charitable trading activities
Unrestricted
funds
2025
£
Merchandise sales
3,620
Suppliers directory
14,384
Cardholder scheme
1,540
Professional services
8,019
27,563		 Total
funds
2025
£
144,955
28,642
173,597
Total
funds
2024
£
139,505
31,310
170,815
Total
funds
2025
£
3,620
14,384
1,540
8,019
27,563

Page 23

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

15. Income from other trading activities (continued)

Income from non charitable trading activities (continued)

Merchandise sales
Support groups
Suppliers directory
Cardholder scheme
Professional services		 Unrestricted
funds
2024
£
2,926
53
14,150
3,510
10,315
30,954		 Total
funds
2024
£
2,926
53
14,150
3,510
10,315
30,954

16. Investment income

Unrestricted
funds
2025
£
Interest receivable
1,576
Unrestricted
funds
2024
£
Interest receivable
1,481		 Restricted
funds
2025
£
744
Restricted
funds
2024
£
832		 Total
funds
2025
£
2,320
Total
funds
2024
£
2,313

Page 24

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

17. Expenditure on raising funds

Fundraising trading expenses

Unrestricted
funds
2025
£
Staging fundraising events
4,507
Fundraising agents
2,491
6,998
Unrestricted
funds
2024
£
Staging fundraising events
4,467
Fundraising agents
2,258
6,725		 Total
funds
2025
£
4,507
2,491
6,998
Total
funds
2024
£
4,467
2,258
6,725

Page 25

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

18. Analysis of grants payable

Trusts and grants
Trusts and grants		 Grants to
Institutions
2025
£
71,325
Grants to
Institutions
2024
£
30,665		 Total
funds
2025
£
71,325
Total
funds
2024
£
30,665

19. Analysis of expenditure by activities

Unrestricted funds
Restricted funds
Unrestricted funds
Restricted funds		 Charitable
activities
2025
£
313,313
21,803
335,116
Charitable
activities
2024
£
278,628
23,091
301,719		 Grant
funding of
activities
2025
£
-
71,325
71,325
Grant
funding of
activities
2024
£
-
30,665
30,665		 Total
funds
2025
£
313,313
93,128
406,441
Total
funds
2024
£
278,628
53,756
332,384

Page 26

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

19. Analysis of expenditure by activities (continued)

Analysis of direct costs

Unrestricted
funds
2025
£
Staff costs
223,863
Rent and rates
6,160
Insurance
1,086
Website costs
6,163
Platform fees
2,349
Computer software and maintenance costs
7,573
Printing, postage and stationary
1,607
Support groups
2,172
Sundry expenses
7,361
Research and committee costs
1,200
Travel and accommodation
10,206
Events
25,552
General awareness and promotional costs
6,519
Merchandise
4,295
Bank charges
581
Legal and professional fees
6,626
313,313		 Restricted
funds
2025
£
-
-
-
-
-
-
-
3,803
270
-
-
-
17,670
-
60
-
21,803		 Total
funds
2025
£
223,863
6,160
1,086
6,163
2,349
7,573
1,607
5,975
7,631
1,200
10,206
25,552
24,189
4,295
641
6,626
335,116

Page 27

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

19. Analysis of expenditure by activities (continued)

Analysis of direct costs (continued)

Staff costs
Rent and rates
Insurance
Website costs
Platform fees
Computer software and maintenance costs
Printing, postage and stationary
Support groups
Sundry expenses
Research and committee costs
Travel and accommodation
Events
General awareness and promotional costs
Merchandise
Bank charges
Legal and professional fees		 Unrestricted
funds
2024
£
195,311
6,877
244
6,121
2,279
6,410
2,164
2,533
3,730
2,895
9,421
31,934
2,022
959
192
5,536
278,628		 Restricted
funds
2024
£
-
-
-
-
-
-
3
7,100
60
10,220
444
-
5,204
-
60
-
23,091		 Total
funds
2024
£
195,311
6,877
244
6,121
2,279
6,410
2,167
9,633
3,790
13,115
9,865
31,934
7,226
959
252
5,536
301,719

20. Staff costs

Wages and salaries
Contribution to defined contribution pension schemes		 2025
£
203,984
19,879
223,863		 2024
£
179,540
15,771
195,311

The average number of persons employed by the Charity during the year was as follows:

2025 2024
No. No.
Employees 9 7

No employee received remuneration amounting to more than £60,000 in either year.

Page 28

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

21. Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2024 - £NIL) .

During the year ended 31 March 2025, no Trustee expenses have been incurred (2024 - £NIL) .

22.
Stocks
Finished goods and goods for resale
23.
Debtors
Due within one year
Other debtors
Prepayments and accrued income
24.
Creditors: Amounts falling due within one year		 2025
£
2,500
2025
£
12,840
16,341
29,181		 2024
£
2,500
2024
£
4,510
32,534
37,044
Other taxation and social security
Pension fund loan payable
Accruals and deferred income		 2025
£
3,647
1,430
32,468
37,545		 2024
£
4,327
1,487
26,029
31,843

Page 29

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

25. Statement of funds

Statement of funds - current year

Unrestricted funds
General Funds
Restricted funds
Research Funds
VTCT Men
Alopecia Areata Research
Norwich Support Group
Northern Ireland Activities
Pfizer Socioecono
National Lottery Award -
Children & YP Sessional
Workers Project
Research Fund - Other types
Access Foundation
Restricted Awareness
BAD RCGP
Fort Foundation
Total of funds		 Balance at 1
April 2024
£
297,574
1,206
1,808
376,737
440
1,666
1,896
2,162
7,608
-
-
-
-
393,523
691,097		 Income
£
252,766
864
-
-
-
-
-
-
-
5,000
20,520
2,122
1,000
29,506
282,272		 Expenditure
£
(320,311)
347
-
(71,732)
(130)
-
-
(1,263)
-
(1,680)
(17,670)
-
(1,000)
(93,128)
(413,439)		 Transfers
in/out
£
4,603
-
(1,808)
-
-
-
(1,896)
(899)
-
-
-
-
-
(4,603)
-		 Balance at
31 March
2025
£
234,632
2,417
-
305,005
310
1,666
-
-
7,608
3,320
2,850
2,122
-
325,298
559,930

Page 30

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

25. Statement of funds (continued)

Statement of funds - prior year

Unrestricted funds
General Funds
Restricted funds
Research Funds
BAD School Pack
VTCT Men
Aplopecia Areata Research
Norwich Support Group
Northern Ireland Activities
Pfixer Socioecono
National Lottery Award -
Children & YP Sessional
Workers Project
Research Fund - Other types
Total of funds		 Balance at
1 April 2023
£
339,855
9,922
-
3,569
376,092
500
2,159
6,003
8,303
-
406,548
746,403		 Income
£
227,176
952
-
-
31,310
-
-
-
-
8,000
40,262
267,438		 Expenditure
£
(268,988)
(9,669)
(469)
(1,761)
(30,665)
(60)
(493)
(4,107)
(6,141)
(391)
(53,756)
(322,744)		 Transfers
in/out
£
(469)
-
469
-
-
-
-
-
-
-
469
-		 Balance at
31 March
2024
£
297,574
1,205
-
1,808
376,737
440
1,666
1,896
2,162
7,609
393,523
691,097

26. Summary of funds Summary of funds - current year

General funds
Restricted funds		 Balance at 1
April 2024
£
297,574
393,523
691,097		 Income
£
252,766
29,506
282,272		 Expenditure
£
(320,311)
(93,128)
(413,439)		 Transfers
in/out
£
4,603
(4,603)
-		 Balance at
31 March
2025
£
234,632
325,298
559,930

Page 31

ALOPECIA UK

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

26. Summary of funds (continued)

Summary of funds - prior year

General funds
Restricted funds		 Balance at
1 April 2023
£
339,855
406,548
746,403		 Income
£
227,176
40,262
267,438		 Expenditure
£
(268,988)
(53,756)
(322,744)		 Transfers
in/out
£
(469)
469
-		 Balance at
31 March
2024
£
297,574
393,523
691,097

27. Analysis of net assets between funds

Analysis of net assets between funds - current year

Unrestricted
funds
2025
£
Current assets
272,177
Creditors due within one year
(37,545)
Total
234,632		 Restricted
funds
2025
£
325,298
-
325,298		 Total
funds
2025
£
597,475
(37,545)
559,930

Analysis of net assets between funds - prior year

Current assets
Creditors due within one year
Total		 Unrestricted
funds
2024
£
329,416
(31,843)
297,573		 Restricted
funds
2024
£
393,524
-
393,524		 Total
funds
2024
£
722,940
(31,843)
691,097

Page 32

76564L Alopecia UK 2025 03 31 - Final Accounts preparation

Final Audit Report

2025-12-14

Created: 2025-12-12 By: Jo-Anna Cubby (Jo-Anna.Cubby@armstrongwatson.co.uk) Status: Signed Transaction ID: CBJCHBCAABAAC9w-5RIyT-6xvK8GP9U5gLjwQLwE2rn3

"76564L Alopecia UK 2025 03 31 - Final Accounts preparation" History

2025-12-12 - 15:52:33 GMT- IP address: 85.210.241.2

Approval Date: 2025-12-12 - 16:03:24 GMT - Time Source: server- IP address: 46.235.170.216

2025-12-12 - 16:03:26 GMT

2025-12-13 - 14:49:35 GMT- IP address: 52.102.16.165

Signature Date: 2025-12-13 - 14:50:21 GMT - Time Source: server- IP address: 104.28.89.87

Agreement completed.

2025-12-14 - 20:00:59 GMT